Birkenstock Holding Plc

BRIEF

published on 04/16/2024 at 22:22, 7 months 6 days ago

Birkenstock Appoints Megan Kulick as Director of Investor Relations

Investor Relations BIRKENSTOCK Finance Experience Megan Kulick Corporate Appointment
PRESS RELEASE

published on 04/16/2024 at 22:17, 7 months 6 days ago

BIRKENSTOCK ANNOUNCES MEGAN KULICK AS DIRECTOR INVESTOR RELATIONS
BIRKENSTOCK appoints Megan Kulick as Director Investor Relations, showcasing her extensive financial experience. CEO Oliver Reichert praises her credibility and market expertise

BIRKENSTOCK Financial Experience Megan Kulick Director Investor Relations Oliver Reichert
PRESS RELEASE

published on 02/29/2024 at 11:00, 8 months 22 days ago

BIRKENSTOCK REPORTS RECORD FIRST QUARTER 2024 REVENUE, UP 26%
BIRKENSTOCK reports record first quarter 2024 revenue increased by 26% driven by strong demand globally and sustained profitability objectives. Financial highlights and future growth investments discussed

Financial Results BIRKENSTOCK Record Revenue First Quarter 2024 Profitability Objectives
BRIEF

published on 02/29/2024 at 11:00, 8 months 22 days ago

Birkenstock posts record revenue for the first quarter of 2024

Expansion Revenue Growth Profitability Finance BIRKENSTOCK
PRESS RELEASE

published on 01/26/2024 at 22:15, 9 months 27 days ago

BIRKENSTOCK ANNOUNCES FIRST QUARTER FISCAL YEAR 2024 (ENDED DECEMBER 31, 2023) RESULTS DATE AND CONFERENCE CALL
BIRKENSTOCK announces date and details for reporting the first quarter fiscal year 2024 results ended December 31, 2023 and the associated conference call. The global brand embraces all consumers regardless of geography, gender, age, and income, and is committed to encouraging proper foot health.

Financial Results Conference Call BIRKENSTOCK First Quarter Fiscal Year 2024 Foot Health
PRESS RELEASE

published on 11/02/2023 at 11:57, 1 year ago

BIRKENSTOCK PROGRESSES ITS DELEVERAGING PROGRAM AND UTILIZES THE NET IPO PROCEEDS FOR EARLY LOAN REPAYMENT REDUCING LEVERAGE BELOW 2.5X, AND COMMITS TO A LONG-TERM LEVERAGE RATIO TARGET BELOW 1.0X
PRESS RELEASE

published on 10/11/2023 at 21:38, 1 year 1 month ago

Birkenstock Holding plc: BIRKENSTOCK LEAVES ITS FOOTPRINT ON WALL STREET AND TRANSFORMS THE NEW YORK STOCK EXCHANGE
PRESS RELEASE

published on 10/11/2023 at 00:18, 1 year 1 month ago

Birkenstock Holding plc: BIRKENSTOCK ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING

Published on 11/22/2024 at 23:55, 9 hours 28 minutes ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 53 minutes ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 18 minutes ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 10 hours 18 minutes ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 53 minutes ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 15 hours 8 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 15 hours 23 minutes ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 15 hours 30 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 28 minutes ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 23 minutes ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 14:35, 18 hours 48 minutes ago

Thales Press release
Published on 11/21/2024 at 06:58, 2 days 2 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 14 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024

View all LES ECHOS COMFI WIRE

News